H.R. No. 550 is a resolution honoring Dr. Jennifer Keating Litton for her significant contributions to cancer research and treatment at The University of Texas MD Anderson Cancer Center in Houston. Dr. Litton has held various leadership roles, including chief of the Section of Clinical Research and Drug Development and vice president of clinical research, where she oversees the largest cancer clinical trials program in the country. Her involvement extends to numerous professional organizations and committees, and she has received accolades for her work, including the President's Recognition of Faculty Excellence Award in Prevention Outreach from MD Anderson.

The resolution acknowledges Dr. Litton's extensive educational background, including degrees from Duke University, the University of Massachusetts Medical School, and Harvard T. H. Chan School of Public Health, as well as her board certifications in oncology and internal medicine. It recognizes her research focus on pregnancy and breast cancer, genetic testing, and molecular changes in breast cancer genes. The Texas House of Representatives expresses its high regard for Dr. Litton and extends best wishes for her continued success, with an official copy of the resolution to be prepared in her honor.